Aberrant gata-3 expression in human pancreatic cancer

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 2, 2006, Pages 161-169

  Gulbinas, Antanas ^a   Berberat, Pascal O ^a   Dambrauskas, Zilvinas ^a   Giese, Thomas ^a   Giese, Nathalia ^a   Autschbach, Frank ^a   Kleeff, Joerg ^a   Meuer, Stefan ^a   Büchler, Markus W ^a   Friess, Helmut ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gata 3; Pancreas; Pancreatic cancer; TGF

Indexed keywords

MESSENGER RNA; SMAD3 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EXPOSURE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NUCLEAR LOCALIZATION SIGNAL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 32044436980     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.5A6626.2005     Document Type: Article

References (22)

1. Blokzijl A, ten Dijke P, Ibanez CF (2002) Physical and functional interaction between GATA-3 and Smad3 allows TGF-β regulation of GATA target genes. Curr Biol 12:35-45
2. Buchler M, Friess H, Schultheiss KH, Gebhardt C, Kubel R, Muhrer KH, Winkelmann M, et al. (1991) A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 68:1507-1512
3. Ellenrieder V, Buck A, Gress TM (2002) TGFbeta-regulated transcriptional mechanisms in cancer. Int J Gastrointest Cancer 31:61-69
4. Fernandez-Zapico ME, Bramati PS, Zakaria S, Kaczynski JA, Urrutia R (2003) Fundamentals of transcription factors and their impact on pancreatic development and cancer. Pancreatology 3:276-283
5. Friess H, Buchler M, Kruger M, Beger HG (1992) Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin. Pancreas 7:516-521
6. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI, Korc M (1993) Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846-1856
7. Gorelik L, Fields PE, Flavell RA (2000) Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165:4773-4777
8. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353
9. Hoch RV, Thompson DA, Baker RJ, Weigel RJ (1999) GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84:122-128
10. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537
11. Howard TJ (1996) Pancreatic adenocarcinoma. Curr Probl Cancer 20:281-328
12. Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Buchler MW, Falb D, et al. (1999a) The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18:5363-5372
13. Kleeff J, Maruyama H, Friess H, Buchler MW, Falb D, Korc M (1999b) Smad6 suppresses TGF-β-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Biochem Biophys Res Commun 255:268-273
14. Korc M (1998) Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 7:25-41
15. Lim KC, Lakshmanan G, Crawford SE, Gu Y, Grosveld F, Engel JD (2000) Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat Genet 25:209-212
16. Real FX (2003) A "catastrophic hypothesis" for pancreas cancer progression. Gastroenterology 124:1958-1964
17. Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, et al. (1993) Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. Anticancer Res 13:1293-1301
18. Silverberg E, Boring CC, Squires TS (1990) Cancer statistics, 1990. CA Cancer J Clin 40:9-26
19. Steenbergen RD, OudeEngberink VE, Kramer D, Schrijnemakers HF, Verheijen RH, Meijer CJ, Snijders PJ (2002) Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis. Am J Pathol 160:1945-1951
20. Ting CN, Olson MC, Barton KP, Leiden JM (1996) Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384:474-478
21. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS (2000) Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290:134-138
22. Wagner M, Luhrs H, Kloppel G, Adler G, Schmid RM (1998) Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115:1254-1262